• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

不同尺寸球体中光子和电子吸收分数的重新评估。

Re-evaluation of absorbed fractions for photons and electrons in spheres of various sizes.

作者信息

Stabin M G, Konijnenberg M W

机构信息

Departamento de Energia Nuclear, Universidade Federal de Pernambuco, Recife, Brazil.

出版信息

J Nucl Med. 2000 Jan;41(1):149-60.

PMID:10647618
Abstract

UNLABELLED

Absorbed fractions for unit density spheres in an infinite unit density medium, previously calculated for photon emitters and electron emitters, were reevaluated with the Monte Carlo codes EGS4 and MCNP4B.

METHODS

Activity was assumed to be distributed uniformly throughout the spheres, and absorbed fractions for self-irradiation were calculated at discrete photon and electron energies.

RESULTS

For electrons, the codes were in very good agreement with each other (+/-5%) and with published values, except at higher energies in the very smallest spheres, where some differences exceeded 10%. For photons, the codes were again in good agreement with each other but produced results that varied considerably from published MIRD values. For energies <1 MeV and sphere sizes <50 g, the absorbed fractions determined using the Monte Carlo codes were typically 20%-40% higher than values in MIRD 3 and 8. For energies >1 MeV, the Monte Carlo values were sometimes lower than those in the MIRD documents. Recommended values, generally the average results from the 2 Monte Carlo codes, are given for all sphere sizes and energies for both electrons and photons.

CONCLUSION

The absorbed fractions calculated using the Monte Carlo codes should replace the older values and are helpful in evaluating tumor doses, doses to small organs, and other situations in which a uniform distribution of activity throughout a spherical structure of unit density can be assumed.

摘要

未加标注

此前针对光子发射体和电子发射体计算得出的、无限单位密度介质中单位密度球体的吸收分数,使用蒙特卡罗代码EGS4和MCNP4B进行了重新评估。

方法

假设活度在整个球体中均匀分布,并在离散的光子和电子能量下计算自辐照的吸收分数。

结果

对于电子,除了在最小球体的较高能量处,代码之间彼此非常吻合(±5%)且与已发表的值相符,在这些较高能量处一些差异超过了10%。对于光子,代码之间再次吻合良好,但得出的结果与已发表的MIRD值有很大差异。对于能量<1 MeV且球体尺寸<50 g的情况,使用蒙特卡罗代码确定的吸收分数通常比MIRD 3和8中的值高20% - 40%。对于能量>1 MeV的情况,蒙特卡罗值有时低于MIRD文件中的值。给出了针对所有球体尺寸和能量的电子及光子的推荐值,通常是两个蒙特卡罗代码的平均结果。

结论

使用蒙特卡罗代码计算得出的吸收分数应取代旧值,有助于评估肿瘤剂量、对小器官的剂量以及其他可假设活度在单位密度球形结构中均匀分布的情况。

相似文献

1
Re-evaluation of absorbed fractions for photons and electrons in spheres of various sizes.不同尺寸球体中光子和电子吸收分数的重新评估。
J Nucl Med. 2000 Jan;41(1):149-60.
2
Application of the ICRP/ICRU reference computational phantoms to internal dosimetry: calculation of specific absorbed fractions of energy for photons and electrons.ICRP/ICRU 参考计算体模在体内剂量学中的应用:光子和电子的能量比吸收剂量的计算。
Phys Med Biol. 2010 Jul 7;55(13):3631-41. doi: 10.1088/0031-9155/55/13/004. Epub 2010 Jun 4.
3
Impact on 141Ce, 144Ce, 95Zr, and 90Sr beta emitter dose coefficients of photon and electron SAFs calculated with ICRP/ICRU reference adult voxel computational phantoms.光子和电子 SAF 对 ICRP/ICRU 参考成人体素计算体模计算的 141Ce、144Ce、95Zr 和 90Srβ发射体剂量系数的影响。
Health Phys. 2010 Oct;99(4):503-10. doi: 10.1097/HP.0b013e3181c479bf.
4
Absorbed fractions for electrons and beta particles in spheres of various sizes.不同尺寸球体中电子和β粒子的吸收分数。
J Nucl Med. 1994 Jan;35(1):152-6.
5
A Monte Carlo study of cellular S-factors for 1 keV to 1 MeV electrons.关于1keV至1MeV电子的细胞S因子的蒙特卡罗研究。
Phys Med Biol. 2009 Aug 21;54(16):5023-38. doi: 10.1088/0031-9155/54/16/012. Epub 2009 Aug 4.
6
CELLDOSE: a Monte Carlo code to assess electron dose distribution--S values for 131I in spheres of various sizes.CELLDOSE:一种用于评估电子剂量分布的蒙特卡罗代码——不同尺寸球体中¹³¹I的S值。
J Nucl Med. 2008 Jan;49(1):151-7. doi: 10.2967/jnumed.107.045179. Epub 2007 Dec 12.
7
A unified formalism for estimating photon absorbed fractions in spherical biovolumes: analytical equations without fitting parameters.
Biomed Phys Eng Express. 2022 Mar 17;8(3). doi: 10.1088/2057-1976/ac5b8d.
8
Subcellular S-factors for low-energy electrons: a comparison of Monte Carlo simulations and continuous-slowing-down calculations.低能电子的亚细胞S因子:蒙特卡罗模拟与连续慢化计算的比较
Int J Radiat Biol. 2008 Dec;84(12):1034-44. doi: 10.1080/09553000802460180.
9
Fluence to effective dose conversion coefficients calculated for monoenergetic electrons up to 200 MeV in partial exposure geometries.针对部分照射几何条件下能量高达200 MeV的单能电子计算的注量到有效剂量转换系数。
Radiat Prot Dosimetry. 2004;112(3):345-58. doi: 10.1093/rpd/nch412. Epub 2004 Oct 19.
10
A unified approach to photon and beta particle dosimetry.
J Nucl Med. 1994 Oct;35(10):1721-9.

引用本文的文献

1
Novel Lu-Labeled [Thz]Bombesin(6-14) Derivatives with Low Pancreas Accumulation for Targeting Gastrin-Releasing Peptide Receptor-Expressing Cancer.新型低胰腺聚集的镥标记[Thz]蛙皮素(6-14)衍生物用于靶向表达胃泌素释放肽受体的癌症
Pharmaceuticals (Basel). 2025 Mar 23;18(4):449. doi: 10.3390/ph18040449.
2
Synthesis and Evaluation of Ga- and Lu-Labeled [diF-Pro]Bombesin(6-14) Analogs for Detection and Radioligand Therapy of Gastrin-Releasing Peptide Receptor-Expressing Cancer.用于检测和放射性配体治疗表达胃泌素释放肽受体的癌症的镓和镥标记的[二氟-脯氨酸]蛙皮素(6-14)类似物的合成与评价
Pharmaceuticals (Basel). 2025 Feb 8;18(2):234. doi: 10.3390/ph18020234.
3
Evaluation of PET/CT imaging with [89Zr]Zr-DFO-girentuximab: a phase 1 clinical study in Japanese patients with renal cell carcinoma (Zirdac-JP).
[89Zr]Zr-DFO-girentuximab 的 PET/CT 成像评估:日本肾细胞癌患者的 1 期临床研究(Zirdac-JP)。
Jpn J Clin Oncol. 2024 Aug 14;54(8):873-879. doi: 10.1093/jjco/hyae075.
4
Preclinical comparison of [Lu]Lu-rhPSMA-10.1 and [Lu]Lu-rhPSMA-10.2 for endoradiotherapy of prostate cancer: biodistribution and dosimetry studies.[镥]镥-rhPSMA-10.1和[镥]镥-rhPSMA-10.2用于前列腺癌内放射治疗的临床前比较:生物分布和剂量学研究。
EJNMMI Radiopharm Chem. 2024 Feb 26;9(1):18. doi: 10.1186/s41181-024-00246-2.
5
Lys-urea-Aad, Lys-urea-Cmc and Lys-urea-Cms as potential pharmacophores for the design of PSMA-targeted radioligands to reduce off-target uptake in kidneys and salivary glands.Lys-urea-Aad、Lys-urea-Cmc 和 Lys-urea-Cms 作为设计 PSMA 靶向放射性配体的潜在药效团,以减少肾脏和唾液腺的非靶位摄取。
Theranostics. 2023 Aug 15;13(13):4559-4573. doi: 10.7150/thno.87663. eCollection 2023.
6
Heterogeneity of absorbed dose distribution in kidney tissues and dose-response modelling of nephrotoxicity in radiopharmaceutical therapy with beta-particle emitters: A review.β粒子发射放射性药物治疗中肾组织内吸收剂量分布的异质性与肾毒性的剂量反应建模:综述。
Z Med Phys. 2024 Nov;34(4):491-509. doi: 10.1016/j.zemedi.2023.02.006. Epub 2023 Apr 6.
7
Radiolysis-Associated Decrease in Radiochemical Purity of Lu-Radiopharmaceuticals and Comparison of the Effectiveness of Selected Quenchers against This Process.辐射分解相关的镥放射性药物放射化学纯度降低及几种淬灭剂对此过程效果的比较。
Molecules. 2023 Feb 16;28(4):1884. doi: 10.3390/molecules28041884.
8
Safety of [Lu]Lu-NeoB treatment: a preclinical study characterizing absorbed dose and acute, early, and late organ toxicity.[Lu]Lu-NeoB 治疗的安全性:一项特征吸收剂量以及急性、早期和晚期器官毒性的临床前研究。
Eur J Nucl Med Mol Imaging. 2022 Nov;49(13):4440-4451. doi: 10.1007/s00259-022-05926-2. Epub 2022 Aug 11.
9
A feasibility study of the therapeutic application of a mixture of Cu radioisotopes produced by cyclotrons with proton irradiation.用回旋加速器产生的 Cu 放射性同位素混合物经质子辐照治疗应用的可行性研究。
Med Phys. 2022 Apr;49(4):2709-2724. doi: 10.1002/mp.15524. Epub 2022 Feb 20.
10
Whole-body biodistribution and radiation dosimetry of [F]PR04.MZ: a new PET radiotracer for clinical management of patients with movement disorders.[F]PR04.MZ的全身生物分布及辐射剂量测定:一种用于运动障碍患者临床管理的新型正电子发射断层显像(PET)放射性示踪剂
EJNMMI Res. 2022 Jan 10;12(1):1. doi: 10.1186/s13550-021-00873-9.